---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-274553"
form_type: "8-K"
ticker: "EW"
cik: "0001099800"
company_name: "Edwards Lifesciences Corp"
filed_at: "2022-11-01T23:59:59+00:00"
generated_at: "2026-06-22T17:00:58.835231+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Edwards Lifesciences announces $750M accelerated share repurchase, initial ~8M shares

## Summary
- $750M ASR executed; initial delivery of ~8M shares, remainder based on VWAP over term.
- Total 2022 repurchases exceed $1.7 billion.
- Approximately $900 million remains in board-authorized repurchase plan.
- Repurchase funded with existing cash.

## SEC filing metadata
- accession: 0001193125-22-274553
- form_type: 8-K
- ticker: EW
- cik: 0001099800
- company_name: Edwards Lifesciences Corp
- filed_at: 2022-11-01T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1099800/000119312522274553/0001193125-22-274553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1099800/000119312522274553/d414194d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-274553
- JSON: https://secwatch.observer/filing/0001193125-22-274553.json
- Plain text: https://secwatch.observer/filing/0001193125-22-274553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.